NCT01597895 - Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Healthy

Interventions

DRUG

Maraviroc

Maraviroc 150 mg BID x 5 days with food

DRUG

Maraviroc + Boceprevir

Maraviroc 150 mg BID + Boceprevir 800 mg TID x 10 days with food

DRUG

Maraviroc + Telaprevir

Maraviroc 150 mg BID + Telaprevir 800 mg TID x 10 days with food

Trial Locations (1)

Pfizer Investigational Site, Brussels